Assessing the Safety of Inhaled Zanamivir Exposure in Pregnant Women

Trial Profile

Assessing the Safety of Inhaled Zanamivir Exposure in Pregnant Women

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2014

At a glance

  • Drugs Zanamivir (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 18 Apr 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 22 Feb 2013 Planned number of patients 1 added as reported by ClinicalTrials.gov.
    • 02 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top